{"id":"doi:10.1038/s41573-025-01183-8","kind":"review","title":"GLP-1-based therapies for diabetes, obesity and beyond","authors":["Daniel J. Drucker"],"author_count":1,"year":2025,"published":"2025-04-25","venue":"Nature Reviews Drug Discovery","cited_by":247,"doi":"10.1038/s41573-025-01183-8","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41573-025-01183-8","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41573-025-01183-8","updated":null,"pmid":"40281304","pmcid":null,"openalex_id":"W4409787462","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}